CAS Activators
The class of chemicals known as CAS activators comprises a diverse array of compounds that exhibit the unique ability to influence the activation of the CAS protein through various signaling pathways. These chemicals encompass inhibitors of specific kinases, modulators of calcium homeostasis, and regulators of key intracellular signaling cascades. One common theme among these CAS activators is their indirect mode of action, orchestrating a cascade of events that culminate in the activation of CAS. The signaling pathways targeted by CAS activators include the Wnt/β-catenin pathway, where lithium chloride disrupts the destruction complex and stabilizes β-catenin, leading to CAS activation. Thapsigargin, by perturbing calcium homeostasis, triggers downstream cascades involving calmodulin, ultimately influencing CAS activation. Forskolin, through the stimulation of adenylate cyclase and increased cAMP levels, activates protein kinase A (PKA), resulting in CAS phosphorylation and activation.
Additionally, chemicals like dorsomorphin and bisindolylmaleimide I demonstrate the intricate interplay between CAS and AMP-activated protein kinase (AMPK) or protein kinase C (PKC), respectively. These chemicals highlight the role of specific kinases in the modulation of CAS activation. Sodium orthovanadate, on the other hand, interferes with tyrosine phosphatases, showcasing the importance of tyrosine phosphorylation in CAS activation. The indirect nature of CAS activation is further exemplified by compounds like SB-431542, Y-27632, and BAY 11-7082, which influence CAS through inhibition of TGF-β signaling, Rho-associated protein kinase (ROCK), and NF-κB activation, respectively. Each of these chemicals provides unique insights into the intricate regulatory network governing CAS activation, emphasizing the diversity of cellular processes that can be harnessed to modulate CAS activity. In summary, the chemical class of CAS activators encompasses a broad range of compounds that exert their influence through various cellular pathways. This detailed understanding of the biochemical mechanisms underlying CAS activation by these chemicals contributes to our knowledge of signal transduction and regulatory networks within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride activates CAS indirectly by modulating the Wnt/β-catenin pathway. It inhibits GSK-3β, a key component in the destruction complex, leading to β-catenin stabilization and subsequent activation of CAS. This demonstrates a clear connection between lithium chloride, the Wnt pathway, and CAS activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces CAS activation indirectly by disrupting calcium homeostasis. By inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), thapsigargin increases cytoplasmic calcium levels. This elevated calcium triggers downstream signaling cascades, including those involving calmodulin, ultimately leading to CAS activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates CAS indirectly by stimulating adenylate cyclase and increasing intracellular cAMP levels. Elevated cAMP activates protein kinase A (PKA), which subsequently phosphorylates and activates CAS. This delineates the specific biochemical pathway through which forskolin influences CAS activation. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Dorsomorphin (BML-275) acts as an indirect CAS activator by inhibiting AMP-activated protein kinase (AMPK). Inhibition of AMPK leads to decreased phosphorylation of CAS, promoting its activation. This establishes a direct link between dorsomorphin, AMPK inhibition, and CAS activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I activates CAS indirectly by inhibiting protein kinase C (PKC). PKC inhibition disrupts downstream signaling pathways, including those involving CAS phosphorylation. Thus, bisindolylmaleimide I provides a mechanistic insight into how PKC modulation can influence CAS activation. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an indirect CAS activator that inhibits protein tyrosine phosphatases (PTPs). By preventing PTP activity, it enhances tyrosine phosphorylation of CAS, leading to its activation. This highlights the crucial role of tyrosine phosphorylation in CAS activation and how sodium orthovanadate manipulates this process. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 acts as an indirect CAS activator by inhibiting the TGF-β receptor. Inhibition of TGF-β signaling prevents the downstream suppression of CAS, allowing for its activation. This exemplifies the intricate interplay between TGF-β signaling, CAS, and the specific mechanism through which SB-431542 influences CAS activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 indirectly activates CAS by inhibiting Rho-associated protein kinase (ROCK). Inhibition of ROCK disrupts actin cytoskeleton dynamics, affecting CAS localization and activation. This elucidates the connection between Y-27632, ROCK inhibition, and the subsequent activation of CAS. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an indirect CAS activator that inhibits NF-κB activation. By suppressing NF-κB, BAY 11-7082 prevents the transcriptional repression of CAS, leading to its activation. This provides a detailed understanding of how BAY 11-7082 influences CAS activation through the modulation of NF-κB signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates CAS indirectly by modulating the SIRT1 pathway. Activation of SIRT1 by resveratrol influences downstream signaling events, including those involving CAS, leading to its activation. This sheds light on the intricate connection between resveratrol, SIRT1, and CAS activation at the molecular level. | ||||||